THE WORLD'S COVID-19 VACCINE

Serial Number 97225501
807

Registration Progress

Application Filed
Jan 18, 2022
Under Examination
May 20, 2025
Approved for Publication
Mar 25, 2025
Published for Opposition
Mar 25, 2025
Registered

Attorney Assistance

Non-Final Action E-Mailed
Due: Apr 17, 2026 79 days

Trademark Image

THE WORLD'S COVID-19 VACCINE

Basic Information

Serial Number
97225501
Filing Date
January 18, 2022
Published for Opposition
March 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
807
Status Date
Jan 17, 2026
Application
Pending
Classes
044

Rights Holder

Texas Children's Hospital

99
Address
6651 Main Street
Houston, TX 77030

Ownership History

Texas Children's Hospital

Original Applicant
99
Houston, TX

Texas Children's Hospital

Owner at Publication
99
Houston, TX

Legal Representation

Attorney
James W. Repass

USPTO Deadlines

Next Deadline
79 days remaining
Non-Final Action E-Mailed
Due Date
April 17, 2026
Extension Available
Until July 17, 2026

Application History

36 events
Date Code Type Description Documents
Jan 17, 2026 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 17, 2026 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 17, 2026 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Nov 21, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 18, 2025 IUAF S USE AMENDMENT FILED Loading...
Nov 18, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 20, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 26, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 16, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 16, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 16, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 15, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Oct 15, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jul 16, 2024 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jul 16, 2024 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jul 16, 2024 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Jul 16, 2024 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Apr 22, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 16, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Mar 30, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Feb 15, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 31, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 30, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Sep 30, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 26, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 24, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Providing information about the prevention and treatment of COVID-19
First Use Anywhere: Dec 28, 2021
First Use in Commerce: Dec 28, 2021

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"COVID-19 VACCINE"